ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,253Medicare Part D Prescriptions Filled, Including Refills

Rank: 949 out of 6645

$305K Total Retail Price of All Prescriptions

Rank: 2449 out of 6645

365 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,943 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 588 573 1 1
LISINOPRIL 501 491 2 3
ALENDRONATE SODIUM 463 460 3 14
OMEPRAZOLE 435 413 4 6
METFORMIN HCL 373 354 5 7
AMLODIPINE BESYLATE 368 345 6 2
ATENOLOL 353 350 7 8
LEVOTHYROXINE SODIUM 290 288 8 4
FINASTERIDE 264 264 9 73
HYDROCHLOROTHIAZIDE 263 254 10 9
LOVASTATIN 246 246 11 15
CITALOPRAM HBR 235 224 12 35
BENAZEPRIL HCL 218 210 13 21
DOXAZOSIN MESYLATE 197 197 14 81
FUROSEMIDE 194 191 15 11
TAMSULOSIN HCL 160 160 16 22
FELODIPINE ER 158 158 17 105
LOSARTAN POTASSIUM 156 145 18 12
PANTOPRAZOLE SODIUM 149 145 19 29
GLIPIZIDE 141 138 20 23
DIOVAN 137 132 21 19
ATORVASTATIN CALCIUM 118 104 22 10
DONEPEZIL HCL 113 113 23 27
DILTIAZEM 24HR ER 110 104 24 187
RANITIDINE HCL 108 100 25 51
DILTIAZEM ER 91 91 26 182
CARVEDILOL 87 87 27 25
METOPROLOL TARTRATE 79 78 28 13
ACTONEL 76 76 29 92
BENICAR 70 70 30 84
TRAMADOL HCL 69 68 31 30
POTASSIUM CHLORIDE 67 67 32 28
LIPITOR 62 45 33 69
PROAIR HFA 61 55 34 32
CLOPIDOGREL 60 52 35 36
ZOLPIDEM TARTRATE 58 58 36 17
SPIRIVA 57 57 37 65
GABAPENTIN 55 49 38 18
NAMENDA 55 55 38 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.